收藏切换
Application Progress of Bacteriophage in the Treatment of Multidrug-Resistant Bacterial Pneumonia
收藏切换
PDF
Hanyu FU1, Ling CAO1, *, Lin GAN2, Jing YUAN2
Chinese Pharmaceutical Journal | 2024, 59(6) : 549 - 554
Less
收藏切换
Chinese Pharmaceutical Journal | 2024, 59(6): 549-554
Original article
Application Progress of Bacteriophage in the Treatment of Multidrug-Resistant Bacterial Pneumonia
Full
Hanyu FU1, Ling CAO1, *, Lin GAN2, Jing YUAN2
Affiliations
  • 1 Department of Pulmonology, The Affiliated Children's Hospital, Capital Institute of Pediatrics, Beijing 100020, China
  • 2 Department of Bacteriology, Capital Institute of Pediatrics, Beijing 100020, China
Published: 2024-03-22
Outline
收藏切换

OBJECTIVE To review the latest progress of phage therapy in clinical application of multiple multidrug-resistant bacterial pneumonia, in order to provide documentary evidence for the application of phage in pulmonary infection. METHODS The keywords “phage” or “phage therapy” or “phage endolysin” or “engineered phage” and “pneumonia” were used in literature search on CNKI and pubmed, and the retrieved case reports were reviewed according to pathogen classification. RESULTS Clinical studies on randomized controlled trial(RCT) of phage therapy for the treatment of pneumonia had not been publicly reported, but phage had achieved good efficacy in the treatment of pneumonia infected by Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae and Acinetobacter baumannii, and only one adverse reaction had been reported. At the same time, this paper discussed the current difficulties of bacteriophage therapy, such as bacterial resistance, its own safety or the influence of immune system on its efficacy, and the latest development direction of phage endolysin and engineered phage therapy. CONCLUSION Bacteriophages have a promising future in the treatment of respiratory infections, especially those caused by multidrug-resistant bacteria. In the future, more in vivo studies may be needed to answer questions about the efficacy and safety of phage derivatives or engineered phage therapy.

bacteriophage  /  multidrug resistance bacteria  /  bacteriophage lysin  /  engineered phage  /  pneumonia
Hanyu FU, Ling CAO, Lin GAN, Jing YUAN. Application Progress of Bacteriophage in the Treatment of Multidrug-Resistant Bacterial Pneumonia[J]. Chinese Pharmaceutical Journal, 2024 , 59 (6) : 549 -554 .
Year 2024 volume 59 Issue 6
PDF
92
45
Cite this Article
BibTeX
Article Info
  • Receive Date:2022-08-01
  • Online Date:2026-04-08
  • Published:2024-03-22
Article Data
Affiliations
History
  • Received:2022-08-01
Affiliations
    1 Department of Pulmonology, The Affiliated Children's Hospital, Capital Institute of Pediatrics, Beijing 100020, China
    2 Department of Bacteriology, Capital Institute of Pediatrics, Beijing 100020, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT